Every year on February 4th, #WorldCancerDay is led by Union for International Cancer Control (UICC). through this global initiative the UICC strives to raise awareness, improve education, and ignite government action in the fight against cancer. This year’s WCD theme is #UnitedbyUnique, placing people at the center of care and exploring new ways of making a difference. Every experience with cancer is unique and it will take all of us, united, to create a world where we look beyond the disease and see the person before the patient. 

While there is much work to be done to manifest the UICC vision, Hapatune wishes to recognize some of the most recent oncology drug approvals by the FDA across three different modalities:

  • In May 2025, AbbVie received accelerated FDA approval of EMRELIS™ (telisotuzumab vedotin-tllv), an antibody-drug conjugate targeting the c-Met protein. EMRELIS is used to trate patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) with high c-Met overexpression that has progressed after prior systemic therapy.
  • In July 2025, Regeneron was granted approval for LYNOZIFIC™ (linvoseltamab-gcpt), a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager used to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies.
  • In December 2025, the FDA’s approval of Bristol Myers Squibb’s Breyanzi® (Lisocabtagene maraleucel), a CD19-directed CAR-T cell therapy, was expanded to treat adults with relapsed or refractory marginal zone lymphoma (MZL) after at least two prior lines of systemic therapy.

From ADC’s to bispecifics to CAR-T treatments, the cancer treatment portfolio continues to diversify, offering new hope to cancer patients everywhere. We honor the R&D scientists, process development experts, process engineers, quality assurance specialists, manufacturing operators, regulatory affairs members, administrators, supply chain specialist, raw material providers, tools providers, CROs, and CDMOs for their amazing and sometimes unheralded contributions to cancer treatment.

Together, let’s work to create a world without cancer!